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and low birth weight babies. [3, 8] Based on the current evidence and expert opinions, Infectious Diseases Society of America [3] and US Preventive Service Task Force Recommendation [9] recommend urine culture for screening every pregnant woman for asymptomatic bacteriuria at least once between 12 and 16 weeks' gestation or during the first prenatal visit. If the test results come positive, the woman should be treated with antimicrobials.
An estimated 213 million pregnancies occur in a year worldwide [10] and 60% of these attend antenatal checkups. [11] The recommended test for screening this large population for asymptomatic bacteriuria, urine culture, is hardly suitable for this task. It is resource intensive, unaffordable, and not available [12] in low-resource settings where the majority of pregnant women come for antenatal checkups. It needs a laboratory setup [13] with incubator, autoclave, laminar airflow and dedicated air-conditioned space, resources for streaking, performing reactions for identification, and conducting disk-diffusion for antibiotic susceptibility. It is not user-friendly and needs trained personnel to execute the test, making it even more difficult for grass-root staff to provide this test. Further, it takes 48-72 h to give results when done manually and 24 h when expensive automated systems are used. It is difficult for a woman to come back to the hospital on the 2 nd or 3 rd day, when the culture and sensitivity reports come. For these reasons, screening each pregnant woman for asymptomatic bacteriuria requires a test which is rapid, valid, inexpensive, user-friendly, and which provides antibiotic susceptibility so as to facilitate evidence-based prescription for positive cases without needing a repeat visit.
Rationale
The rationale of this mini-review was that it was needed to know whether we have a suitable test for screening asymptomatic bacteriuria in large population with potential for providing evidence-based prescription quickly or there is a gap in research, so as to suggest a basis for further research.
Objective
The objectives of the review were to find out: 1. What are the tests researched for screening asymptomatic bacteriuria or diagnosing UTI in published literature? 2. Are they rapid, valid, affordable, and user-friendly for use in large population? 3. Do they screen or diagnose multiple bacteria and provide antibiotic susceptibility? metHods This review is designed as a narrative review. Methods of conducting the review and eligibility criteria were documented in advance. Diagnostic accuracy studies researching diagnostic tests for UTI or screening tests for asymptomatic bacteriuria in humans as compared to urine culture were included. All types of published articles were considered irrespective of year or language of publication. Participants of any age group screened for asymptomatic bacteriuria or diagnosed with UTI in any level of care hospital were considered. The primary outcome measure was cases of UTI or asymptomatic bacteriuria correctly diagnosed by the tests.
Studies were identified by searching electronic database of Medline. Two searches were conducted on PubMed using the following search terms: 1. "Urinary tract infection" and "diagnostic test" 2. "Asymptomatic bacteriuria" and "screening test."
No filters were applied. Eligibility assessment was done by two reviewers independently in an unblinded standardized manner by screening the titles and abstracts. Full-text publications were reviewed for selected papers. Disagreement between reviewers was resolved by consultation with other coauthors. Two studies required arbitration about selection, the remaining were agreed independently by the reviewers. The last search was run on June 19, 2019. An Excel-based data extraction sheet was developed and piloted on five randomly selected studies. One reviewer extracted data from included studies and the second author validated the extracted data. No disagreement was encountered in data extraction. Information was extracted from each included study on-1. Characteristics of participants -age, presence of symptoms, cohorts 2. Details of intervention, name, automated or manual, intended use, comparator 3. Outcomes and results of tests conducted; cutoff points used 4. Study design, sample size, prospective nature.
The risk of bias in individual studies was assessed by looking at their sample size and prospective nature.
Sensitivity, specificity, likelihood ratios, or receiver operating characteristic were considered the principal summary measures. Sensitivity and specificity above 80% were considered as valid. Likelihood ratios were converted to sensitivity and specificity. Among the studies describing the similar intervention, the highest diagnostic accuracy was considered. Studies were reviewed for explicit mention of terms rapid, cost-effective/ affordable, or user-friendly, and the description of index test was reviewed for determining these criteria.
Screening only one database and only published articles introduced publication bias. No additional analyses were performed.
Results
Seventy-eight records were retrieved from the electronic database, while 25 studies were retained for qualitative synthesis [ Figure 1 ]. The researchers had studied 11 individual tests and 7 combinations of various tests [ Figure 1 ]. The report characteristics and study characteristics are described in Table 1 .
In one study, diagnostic accuracy was separately described for males and females, while in two of the studies, separate cohorts of asymptomatic and symptomatic patients were evaluated. Since the review is concerned with asymptomatic women, the diagnostic accuracy in asymptomatic patients and female patients were considered. Out of 15 tests studied in 25 papers [ Table 2 ], all were rapid in nature, but only seven were valid, namely, genetic signature identification CAPTURE assay, microfluidics-based direct single-cell imaging test, biosensor assay and phenotypic antimicrobial susceptibility test, chromogenic Limulus amoebocyte lysate assay, Gram staining, urine particle analyser UF-1000i, and flow cytometry-based leukocyte count (UF 100). Out of these tests, review of required infrastructure as described in the papers revealed that Gram staining and chromogenic Limulus amoebocyte lysate assay were cost-effective for use in large population. While the study on chromogenic Limulus amoebocyte lysate assay explicitly mentioned that it was user-friendly, the procedure to conduct Gram stain was deemed to be user-friendly by the authors.
None of the 15 tests was equipped to provide both identification of common uropathogens as well as susceptibility to various antibiotics for evidence-based prescription at the time of the first contact itself. Biosensor assay identified Enterobacteriaceae but gave susceptibility to only ciprofloxacin. CAPTURE assay identified common uropathogens but did not provide antibiotic susceptibility. Microfluidics-based test identified only E. coli and provided susceptibility to only ciprofloxacin. Gram staining could differentiate Gram-positive bacteria from dIscussIon Many hospitals in low-resource settings, lack the resources to screen every pregnant woman using the urine culture, and sensitivity test. As a result, they either do not screen them at all or screen them with tests having low diagnostic accuracy.
In our review of the literature, none of the alternative tests tried in the past had all the characteristics of a suitable test for screening asymptomatic bacteriuria, namely, rapid, valid, user-friendly, affordable, and providing identification and antibiotic sensitivity. Most of the tests just provided an initial triage of UTI so as to reduce the need of running urine culture for every sample. A positive woman on screening had to still undergo urine culture and wait for 2 days for initiation of appropriate antibiotic therapy, which in reality never happens. The women fail to come back to the hospital on the 2 nd or 3 rd day, when the culture and sensitivity reports come, due to many factors like lack of conveyance, cost of transportation, lack of compliance, and discomfort of repeated visits. Hence, they fail to avail adequate treatment with desirable and effective antimicrobials.
This reveals a state of affairs where 40% women [11] do not turn up for antenatal checkups, among the rest, majority do not get an early diagnosis and initiation of appropriate antibiotics. This leaves an unmet need in adequately screening the pregnant women during early pregnancy for asymptomatic bacteriuria, contributing to adverse outcomes of pregnancy.
Similarly, in cases of symptomatic pregnant women, treating physicians are unable to timely find out the causative organism and susceptibility. They are forced to mostly rely on their clinical judgment and prescribe wide-spectrum antibiotics empirically. Nonevidence-based irrational and unnecessary drug prescription of antibiotics has raised the rate of development of antimicrobial resistance for several commonly used broad-spectrum antibiotics. [38] Despite the limitations like not being an extensive search in various databases and unpublished articles, the review provided an insight into why pregnant women are not being screened routinely and how it is contributing to a rise in cases of prematurity.
According to United States Preventive Services Task Force (USPTF), it is urgently needed to develop a test, which can screen for asymptomatic bacteriuria and is less labor-intensive at a lower cost too. [9] The authors also conclude that for making this testing possible in all health-care settings, further research is needed to provide an affordable, easy, rapid, and valid test for identification of bacteria and antibiotic sensitivity. Failing to do so will leave asymptomatic bacteriuria undiagnosed and will cause adverse outcomes of pregnancy.
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Gram-negative bacteria. While the rest of the 11 tests were used in the role of triage tests for initial diagnosis of UTI to reduce the burden of performing urine culture on every sample.
No combination of tests proved to be valid unequivocally. Nitrite and leukocyte esterase together showed validity in two studies but failed to show validity in five studies. 
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